{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:24:30Z","timestamp":1772472270988,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education, Poland","award":["N402 086 32\/2962"],"award-info":[{"award-number":["N402 086 32\/2962"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.leukres.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T11:12:27Z","timestamp":1528024347000},"page":"74-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5053-2967","authenticated-orcid":false,"given":"Hanna","family":"Janiszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"B\u0105k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Skonieczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ja\u015bkowiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kie\u0142bi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jachalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Czy\u017cewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Ja\u017awiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Kuliszkiewicz-Janus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Czy\u017c","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazimierz","family":"Kuliczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Haus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.05.013_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2018.05.013_bib0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jmcb\/mju045","article-title":"CHK2 kinase in the DNA damage response and beyond","volume":"6","author":"Zannini","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.leukres.2018.05.013_bib0015","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1042\/BST0381704","article-title":"Loss of the tumour-suppressor genes CHK2 and BRCA1 results in chromosomal instability","volume":"38","author":"Stolz","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.leukres.2018.05.013_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ncb2051","article-title":"The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells","volume":"12","author":"Stolz","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.leukres.2018.05.013_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0145-2126(00)00130-2","article-title":"Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias","volume":"25","author":"Hofmann","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.05.013_bib0030","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1182\/blood.V99.8.3075","article-title":"Mutations of Chk2 in primary hematopoietic neoplasms","volume":"99","author":"Hangaishi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.05.013_bib0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0145-2126(02)00075-9","article-title":"Analysis of CHK2 in patients with myelodysplastic syndromes","volume":"26","author":"Aktas","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.05.013_bib0040","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1373\/clinchem.2004.038331","article-title":"Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies","volume":"50","author":"Collado","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.leukres.2018.05.013_bib0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2006.044974","article-title":"A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer","volume":"43","author":"Cybulski","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.leukres.2018.05.013_bib0050","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2018.05.013_bib0055","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.leukres.2018.05.013_bib0060","series-title":"An International System for Human Cytogenomic Nomenclature","author":"McGowan-Jordan","year":"2016"},{"key":"10.1016\/j.leukres.2018.05.013_bib0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.2007.06566.x","article-title":"Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review","volume":"137","author":"Baldus","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.05.013_bib0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.05.013_bib0075","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2014-03-560227","article-title":"Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia","volume":"124","author":"Malcovati","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.05.013_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.12515","article-title":"The molecular pathogenesis of the myelodysplastic syndromes","volume":"95","author":"Pellagatti","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2018.05.013_bib0085","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/leu.2017.86","article-title":"The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia","volume":"31","author":"Eisfeld","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.05.013_bib0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.13559","article-title":"The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera","volume":"173","author":"Janiszewska","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.05.013_bib0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3324\/haematol.2011.049494","article-title":"A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations","volume":"97","author":"Janiszewska","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.05.013_bib0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-006-9320-y","article-title":"A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland","volume":"102","author":"Cybulski","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.leukres.2018.05.013_bib0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346094","article-title":"Mutations in CHEK2 associated with prostate cancer risk","volume":"72","author":"Dong","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.leukres.2018.05.013_bib0110","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1074\/jbc.M211202200","article-title":"Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody","volume":"278","author":"Tsvetkov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2018.05.013_bib0115","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1073\/pnas.1525129113","article-title":"CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly","volume":"113","author":"Ertych","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2018.05.013_bib0120","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1210214","article-title":"Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations","volume":"333","author":"Janssen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.leukres.2018.05.013_bib0125","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/onc.2009.69","article-title":"Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome","volume":"28","author":"Boehrer","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2018.05.013_bib0130","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T21:09:28Z","timestamp":1571432968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"alternative-id":["S0145212618301152"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.05.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}